Dyadic Yoga Program for Lung Cancer Patients and Caregivers

This study is testing a mobile app that delivers an unsupervised yoga program for people with non-small cell lung cancer who are receiving radiation therapy to the chest (thoracic radiotherapy) and their family caregivers. The goal is to see how easy the app is to use, if it's practical for people to participate, and if they find it acceptable. The study will involve about 60 participants in total. You might be able to join if you have non-small cell lung cancer and are getting at least 24 radiation treatments, have a good physical ability (ECOG performance status of <2), and have a family caregiver who is willing to participate with you. Both you and your caregiver must be over 18 years old. The study is currently unclear on its recruitment status.

Study design
This is an interventional study that will enroll about 60 participants. It aims to test an app-based yoga program.
What's involved
Participants will complete one 60-minute "Thinking out Loud Session" with a yoga therapist, either in person or via Zoom. The study also includes pre- and post-intervention assessments of physical function and quality of life, along with semi-structured interviews.
Compensation
Not stated in the trial record.
Follow-up
Safety and adverse events will be measured through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06919874

Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery

Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~60 participants
Updated 2026-01-09 on ClinicalTrials.gov
What's tested:Thinking out Loud Session

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Safety and Adverse Events (AEs)
Measured over Through study completion; an average of 1 year.
Non-Small Cell Lung Cancer
1 sites across 1 states
Texas1
  • Kathrin Milbury, MA,PHD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Safety and Adverse Events (AEs)Through study completion; an average of 1 year.

    Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0